Financhill
Back

Recursion Pharmaceuticals Vs. Lululemon Athletica Industry Stock Comparison

Sell
32

RXRX
Recursion Pharmaceuticals

Last Price:
$5.85
Seasonality Move:
-20.8%
Sell
29

LULU
Lululemon Athletica

Last Price:
$229.74
Seasonality Move:
6.3%
Sell
32
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.84. The Score for RXRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Lululemon Athletica (LULU) is a Sell

Is Lululemon Athletica a Buy, Sell or Hold?

  • The current Lululemon Athletica [LULU] share price is $229.77. The Score for LULU is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • LULU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight selling pressure.

LULU Stock Price Chart

What is Lululemon Athletica's stock price today?

  • The Lululemon Athletica share price today is $229.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LULU is experiencing slight selling pressure.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.54 Buy
Relative Strength Index (14 RSI): 61.59 Buy
Chaikin Money Flow: -9312955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.97 - 5.47) Buy
Bollinger Bands (100): (4.45 - 6.39) Buy

LULU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 63.84 Buy
Relative Strength Index (14 RSI): 38.98 Sell
Chaikin Money Flow: -788813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (228.37 - 241.97) Sell
Bollinger Bands (100): (243.25 - 326.97) Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.48 Buy
20-day SMA: 5.27 Buy
50-day SMA: 4.89 Buy
200-day SMA: 6.24 Sell
8-day EMA: 4.94 Buy
20-day EMA: 3.25 Buy
50-day EMA: 1.65 Buy
200-day EMA: 0.47 Buy

LULU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 231.4 Sell
20-day SMA: 234.4 Sell
50-day SMA: 270.35 Sell
200-day SMA: 315.73 Sell
8-day EMA: 206.44 Buy
20-day EMA: 137.36 Buy
50-day EMA: 70.1 Buy
200-day EMA: 19.98 Buy

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.

Lululemon Athletica Earnings Growth & LULU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.13 per share, an increase this year of $1.92 per share, and an increase next year of $0.40 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lululemon Athletica Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):